Relates to adverse determinations related to a step therapy protocol override determination; repealer
Summary
Requires written notice of an adverse determination made by a utilization review agent in relation to a step therapy protocol override determination which includes the clinical review criteria relied upon to make such determination and any applicable alternative prescription drugs subject to the step therapy protocol of the utilization review agent.
Bill status
in committee
3 of 5 stages cleared
Introduction
Jan 2024
Committee Review
Jan 2024
Senate Passage
Jan 2024
Assembly Passage
Governor
Introduced Jan 5, 2024
Last action Jan 29, 2024
Floor votes · Senate Jan 8, 2024
How they voted
21–0
Passed
Total votes 21
Jan 8, 2024
D
Democratic14
100% Yea
R
Republican7
100% Yea
Vote distribution
All Yea
All Nay
Mixed
No data
Full legislative history
Actions timeline
Total actions
4
Key actions
1
Committee
1
Jan 8, 2024
Senate · Passed
Senate Vote: pass (21-0)
senate
Jan 5, 2024
Committee
REFERRED TO RULES
upper
1 primary · 0 co-sponsors
Sponsors
Role
Legislator
Party
State
District
P
NB
Neil Breslin
DDemocratic/Working Families
Ask Maddy
·
AI policy assistant
Ask Maddy about S 8038
Scope: NY
Hi! I can help you understand S 8038. What would you like to know?
Try one of these
i
Maddy answers using official bill text and legislative records. Always verify before sharing.
Sources cited inline